Attached files
| file | filename |
|---|---|
| EX-10.20 - EXHIBIT 10.20 - TG THERAPEUTICS, INC. | tgtx_ex1020.htm |
| EX-32.2 - EXHIBIT 32.2 - TG THERAPEUTICS, INC. | tgtx_ex322.htm |
| EX-32.1 - EXHIBIT 32.1 - TG THERAPEUTICS, INC. | tgtx_ex321.htm |
| EX-31.2 - EXHIBIT 31.2 - TG THERAPEUTICS, INC. | tgtx_ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - TG THERAPEUTICS, INC. | tgtx_ex311.htm |
| EX-21.1 - EXHIBIT 21.1 - TG THERAPEUTICS, INC. | tgtx_ex211.htm |
| 10-K - 10-K - TG THERAPEUTICS, INC. | v031418_10K.htm |
Exhibit
23.1
Consent of Independent Registered Public Accounting
Firm
We consent to the
incorporation by reference in registration statement Nos.
333-181439 and 333-210227 on Form S-8 and registration statement
No. 333- 218293 on Form S-3 of TG Therapeutics, Inc. of our report
dated March 15, 2018 on our audits of the consolidated financial
statements of TG Therapeutics, Inc. and Subsidiaries as of December
31, 2017 and 2016, and for each of the three years in the period
ended December 31, 2017, and our report on our audit of internal
control over financial reporting of TG Therapeutics, Inc. and
Subsidiaries as of December 31, 2017, dated March 15, 2018,
included in this Annual Report on Form 10-K of TG Therapeutics,
Inc. and Subsidiaries for the year ended December 31,
2017.
/s/ CohnReznick
LLP
New York, New
York
March 15,
2018